pre-update Archives

On-Demand Webinar

オフターゲット作用の安全性：Replacing Educated Guesswork with Evidence-Based Risk Assessment

Secondary pharmacology profiling involves the screening of small molecule compounds against a broad range of…

Danielle Pillsbury2023年12月19日

On-Demand Webinar

Survival of the Fittest: Evolving Pharmacokinetic Modeling with Pirana

As regulatory acceptance of models for decision-making grows, so too does the need for optimally…

Danielle Pillsbury2023年12月19日

On-Demand Webinar

First-In-Human (FIH) をより早く実現: 生理学的薬物動態（PBPK）モデリングの力

Advanced Strategies and Best Practices for Predictive Pharmacokinetics using Simcyp™ Discovery Refine your approach…

Danielle Pillsbury2023年12月13日

Blog

Answers to Drug Developers’ Frequent Electronic Common Technical Document Questions

Although the Electronic Common Technical Document (eCTD) has been around for many years, it continues…

Certara2023年12月12日

Fact Sheet

Attain FDA Label Claims for Kinase Inhibitor Drugs with the Simcyp™ Simulator

Simcyp was used by pharma and biotech companies to inform, reduce and/or replace clinical studies…

Certara2023年12月6日

Article

Pharma Focus Europe – Issue 03 – Using AI to Accelerate Drug Development

Authors: Professor Amin Rostami-Hodjegan, Professor Piet van der Graaf This Pharma Focus EU article, co-authored…

Certara2023年12月5日

Announcement

Certara Launches Updated Version of Pirana Modeling Workbench

PRINCETON, N.J.— 2023年12月1日 – Certara, Inc., a global leader in biosimulation, today announced…

Certara2023年12月1日

Publication

Model-informed target identification and validation through combining quantitative systems pharmacology with network-based analysis

Authors: Vijayalakshmi Chelliah, Piet H. van der Graaf One of the main areas where quantitative…

Jim Gallagher2023年11月28日

Publication

Creation of novel sensitive probe substrate and moderate inhibitor models for a comprehensive prediction of CYP2C8 interactions for tucatinib

Authors: Ian E. Templeton, Karen Rowland-Yeo, Hannah M. Jones, Christopher J. Endres, Ariel R. Topletz-Erickson, Hao Sun, Anthony J. Lee A…

Jim Gallagher2023年11月28日

Press Release

Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development

Simcyp Biopharmaceutics helps drug developers replace costly clinical bioequivalence studies and optimize formulations for complex…

Jim Gallagher2023年11月21日

Powered by Translations.com GlobalLink Web Software

pre-update

オフターゲット作用の安全性：Replacing Educated Guesswork with Evidence-Based Risk Assessment

Survival of the Fittest: Evolving Pharmacokinetic Modeling with Pirana

First-In-Human (FIH) をより早く実現: 生理学的薬物動態（PBPK）モデリングの力

Answers to Drug Developers’ Frequent Electronic Common Technical Document Questions

Attain FDA Label Claims for Kinase Inhibitor Drugs with the Simcyp™ Simulator

Pharma Focus Europe – Issue 03 – Using AI to Accelerate Drug Development

Certara Launches Updated Version of Pirana Modeling Workbench

Model-informed target identification and validation through combining quantitative systems pharmacology with network-based analysis

Creation of novel sensitive probe substrate and moderate inhibitor models for a comprehensive prediction of CYP2C8 interactions for tucatinib

Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development

メルマガ登録

クイックアクセス

ソリューション

お問合せ